arrow
J

Julien Sénéschal

hopital saint-andre
H指数:52
被引数:9,108

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A New Phototherapy Regimen Coupled with Oral Vitamin D Supplementation, for the Long-Term Control of Atopic Dermatitis: A French Multicenter, Randomized, Crossover, Pragmatic Trial

一种新型光疗方案联合口服维生素D补充剂,用于特应性皮炎的长期控制:一项法国多中心、随机、交叉、实用性试验

2026-09-110
OAAI
Healthcare Providers’ Perspectives on Nonsegmental Vitiligo Severity, Patient Impact, and Treatment Gaps in the United States and Europe

美国和欧洲医疗保健提供者对非节段性白癜风严重程度、患者影响和治疗差距的视角

2026-08-010
OAAI
AD-REAL: A Prospective, Multinational, Observational Cohort Study of Clinical Effectiveness and Treatment Discontinuation of Oral Systemics for Moderate-to-Severe Atopic Dermatitis

AD-REAL:一项关于中重度特应性皮炎口服系统性药物治疗临床有效性和治疗中断的多国前瞻性观察队列研究

2026-07-300
OA
More than a symptom: itch as an independent clinical contributor in atopic dermatitis - a global-scale study on 15,223 patients

瘙痒不止是一种症状:作为特应性皮炎中独立临床因素的全球性研究——基于15,223例患者的分析

2026-04-110
PRE
Defining Important Aspects of Repigmentation in Vitiligo: Insights From Patients' Perspectives

白癜风再色素沉着重要方面的界定:来自患者视角的见解

2026-03-010
PRE
Retrospective Assessment of Social Rejection Related to Atopic Dermatitis During Childhood and Adolescence: The Scars of Life-Eczema Study

关于儿童和青少年特应性皮炎相关社会排斥的回顾性评估:生命疤痕-湿疹研究

2026-03-010
OAAI
Integrated Clinical Trial and Molecular Profiling Reveals Immune Drivers of Chronic Hand Eczema

整合临床试验与分子谱分析揭示慢性手部湿疹的免疫驱动因素

2026-02-180
OAAI
Long-Term Safety and Efficacy of Tralokinumab in Patients with Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years: Final Results from the Open-Label Extension Trial ECZTEND

特应性皮炎中度至重度患者接受特立珠单抗治疗长达6年的长期安全性与有效性:开放标签扩展试验ECZTEND的最终结果

2026-02-050
OAAI
Long-term efficacy of lebrikizumab in treating head, neck and face involvement in patients with moderate-to-severe atopic dermatitis

中重度特应性皮炎患者头、颈和面部受累的lebrikizumab长期疗效

2026-01-010
OAAI
Randomized, double-blind treatment withdrawal or continuation with ruxolitinib cream in vitiligo: findings from the TRuE-V long-term extension phase 3 study

ruxolitinib乳膏在白癜风中的随机,双盲治疗退出或继续: 来自TRuE-V长期扩展3期研究的结果

2025-12-260
OAAI
Immune control of functional memory CD8 T cells in normal-appearing vitiligo skin

正常外观白癜风皮肤中功能性记忆CD8 T细胞的免疫调控

2025-12-100
OA
Vitiligo

白癜风

2025-12-040
PRE